Mycobacterium celatum infection in two HIV-infected patients treated prophylactically with rifabutin

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 17, Issue 4, 1998, Pages 278-281

  Gholizadeh, Y ^a   Varnerot, A ^b   Maslo, C ^a   Salauze, B ^a   Badaoui, H ^a   Vincent, V ^b   Bure Rossier A ^a  

^a HÔPITAL ROTHSCHILD   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CD4 ANTIGEN; CEFTAZIDIME; CLARITHROMYCIN; CLOFAZIMINE; ETHAMBUTOL; RIFABUTIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBIOTICS, ANTITUBERCULAR; FATAL OUTCOME; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; RIFABUTIN;

EID: 0031822936     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050063     Document Type: Article

References (15)

1. Butler WR, Steven P, O'Connor SP, Yarkus MA, Smithwick RW, Plikaytis BB, Moss CW, Floyd MM, Woodley CL, Kilburn JO, Vadney FS, Gross WM: Mycobacterium celatum sp. nov. International Journal of Systematic Bacteriology (1993) 43:539-548.
2. Butler WR, O'Connor SP, Yarkus MA, Gross WM: Cross reactivity of genetic probe for detection of Mycobacterium tuberculosis with newly described species Mycobacterium celatum. Journal of Clinical Microbiology (1994) 32:536-538.
3. Bull TJ, Shanson DC, Archard LC, Yates MD, Hamid ME, Minnikin DE: A new group (type 3) of Mycobacterium celatum isolated from AIDS patients in the London area. International Journal of Systematic Bacteriology (1995) 45:861-862.
4. Piersimoni C, Tortoli E, De Sio G: Disseminated infection due to Mycobacterium celatum in patient with AIDS. Lancet (1994) 344:332.
5. Haase G, Skopnik H, Batge S, Bottger EC :Cervical lymphadenitis caused by Mycobacterium celatum. Lancet (1994) 344:1020-1021.
6. Tortoli E, Piersimoni C, Bacosi D, Bartoloni A, Betti F, Bono L, Burrini C, De Sio G, Lacchini C, Mantella A, Orsi PG, Penati V, Simonetti MT, Bottger EC: Isolation of the newly described species Mycobacterium celatum from AIDS patients. Journal of Clinical Microbiology (1995) 33:137-140.
7. Dahl DM, Klein D, Morgentaler A: Penile mass caused by the newly described organism Mycobacterium celatum. Urology (1996) 47:266-268.
8. Piersimoni C, Tortoli E, De Lalla F, Nista D, Donato D, Bornigia S, De Sio G: Isolation of Mycobacterium celatum from patients infected with human immunodeficiency virus. Clinical Infectious Diseases (1997) 24:144-147.
9. Zurawski CA, Cage GD, Rimland D, Blumberg HM: Pneumonia and bacteremia due to Mycobacterium celatum masquerading as Mycobacterium xenopi in patients with AIDS: an underdiagnosed problem? Clinical Infectious Diseases (1997) 24:140-143.
10. David H, Lévy-Frébault V, Thorel MF: Méthodes de laboratoire pour mycobactériologie clinique. Institut Pasteur, Paris (1989) pp. 463-474.
11. Kirshner P, Springer B, Vogel U, Meier A, Wrede A, Kiekenbeck M, Bange FC, Bottger EC: Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory. Journal of Clinical Microbiology (1993) 31:2882-2889.
12. Picardeau M, Varnerot A, Rauzier J, Gicquel B, Vincent V: Mycobacterium xenopi IS1395, a novel insertion sequence expanding the IS256 family. Microbiology (1996) 142:2453-2461.
13. Rastogi N, Bauriaud RM, Bourgoin A, Carbonelle B, Chippaux C, Gevaudan MJ, Seng Goh K, Moinard D, Roos P: French multicenter study involving eight test sites for radiometric determination of 10 antimicrobial agents against Mycobacterium avium complex. Antimicrobial Agents and Chemotherapy (1995) 39:638-644.
14. Maslo C, Buré-Rossier A, Girard PM, Gholizadeh Y, Lebrette MG, Rozenbaum W: Clinical and bacteriologic impact of rifabutin prophylaxis for Mycobacterium avium complex infection in patients with human immunodeficiency virus infection. Clinical Infectious Diseases (1997) 24:344-349.
15. Picardeau M, Bull TJ, Prod'hom G, Pozniak AL, Shanson DC, Vincent V: Comparison of a new insertion element, IS1407, with established molecular markers for the characterization of Mycobacterium celatum. International Journal of Systematic Bacteriology (1997) 47:640-644.